Biochemist who discovered GLP-1 named winner of 2026 Kimberly Prize Svetlana Mojsovs studies have led to 'life-changing therapies for type 2 diabetes and obesity' Mojsovs studies demonstrated that GLP-1 stimulates insulin secretion and lowers blood glucose levels, which led to the development of GLP-1 receptor agonists, including semaglutide The $250,000 prize winner will also deliver a public lecture on the Feinberg campus in Chicago Mojsovs career in the laboratory has had a profound impact on human heath globally CHICAGO --- Northwestern University Feinberg School of Medicine and the Simpson Querrey Institute for Epigenetics announced today (Oct
The mechanisms proposed for this protective effect include modulation of inflammatory pathways, reduction of oxidative stress, and improvement of metabolic parameters that contribute to liver carcinogenesis (Wang et al., 2024)
When considering a medical approach, the biggest question is always: how long does it take for GLP-1 to work
A healthcare professional may recommend alternative diabetes or weight management treatments for people with: a personal or family history of thyroid cancer multiple endocrine neoplasia syndrome type 2 (MEN 2) a history of pancreatitis allergic reactions to Rybelsus or any of its components People with diabetic retinopathy, kidney issues, or a tendency for hypoglycemia (low blood sugar) may need careful monitoring while taking Rybelsus, too
Optimize your semaglutide results with these supplements from STAAR LABS
Linear synthesis of long sequences by SPPS is challenging due to the iterative accumulation of impurities and increased susceptibility for aggregation to occur